These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11757776)

  • 1. Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome.
    Masuda A; Nakayama T; Yamanaka T; Hatsutanmaru K; Tei C
    Intern Med; 2001 Nov; 40(11):1158-61. PubMed ID: 11757776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome.
    Masuda A; Nakayama T; Yamanaka T; Koga Y; Tei C
    J Behav Med; 2002 Oct; 25(5):487-97. PubMed ID: 12442563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.
    Reuter SE; Evans AM
    J Intern Med; 2011 Jul; 270(1):76-84. PubMed ID: 21205027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates.
    Plioplys AV; Plioplys S
    Neuropsychobiology; 1995; 32(3):132-8. PubMed ID: 8544970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal carnitine levels in patients with chronic fatigue syndrome.
    Soetekouw PM; Wevers RA; Vreken P; Elving LD; Janssen AJ; van der Veen Y; Bleijenberg G; van der Meer JW
    Neth J Med; 2000 Jul; 57(1):20-4. PubMed ID: 10862998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent.
    Geraghty KJ; Blease C
    J Health Psychol; 2018 Jan; 23(1):127-138. PubMed ID: 27634687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylcarnitine deficiency in chronic fatigue syndrome.
    Kuratsune H; Yamaguti K; Takahashi M; Misaki H; Tagawa S; Kitani T
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S62-7. PubMed ID: 8148455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive behaviour therapy and objective assessments in chronic fatigue syndrome.
    McPhee G
    J Health Psychol; 2017 Aug; 22(9):1181-1186. PubMed ID: 28805529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial.
    Knoop H; Stulemeijer M; de Jong LW; Fiselier TJ; Bleijenberg G
    Pediatrics; 2008 Mar; 121(3):e619-25. PubMed ID: 18310181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome.
    Jones MG; Goodwin CS; Amjad S; Chalmers RA
    Clin Chim Acta; 2005 Oct; 360(1-2):173-7. PubMed ID: 15967423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD003200. PubMed ID: 27995604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003200. PubMed ID: 25674924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behaviour therapy in chronic fatigue syndrome.
    Butler S; Chalder T; Ron M; Wessely S
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):153-8. PubMed ID: 2019842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavior therapy for chronic fatigue syndrome.
    Sharpe M
    Am J Med; 1995 Apr; 98(4):420-1; author reply 421-2. PubMed ID: 7709962
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive behavior therapy for chronic fatigue syndrome.
    Chalder T; Deale A; Wessely S; Marks I
    Am J Med; 1995 Apr; 98(4):419-20; author reply 421-2. PubMed ID: 7709961
    [No Abstract]   [Full Text] [Related]  

  • 16. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases.
    Kuratsune H; Yamaguti K; Lindh G; Evengard B; Takahashi M; Machii T; Matsumura K; Takaishi J; Kawata S; Långström B; Kanakura Y; Kitani T; Watanabe Y
    Int J Mol Med; 1998 Jul; 2(1):51-6. PubMed ID: 9854142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carnitine and disabling fatigue in multiple sclerosis.
    Fukazawa T; Sasaki H; Kikuchi S; Hamada T; Tashiro K
    Psychiatry Clin Neurosci; 1996 Dec; 50(6):323-5. PubMed ID: 9014230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behavioral therapy for chronic fatigue syndrome.
    Chalder T; Deale A; Wessely S
    Clin Infect Dis; 1995 Mar; 20(3):717-8. PubMed ID: 7756505
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive behaviour therapy for the chronic fatigue syndrome. Patients were not representative of all patients with the syndrome.
    Gibbons R; Macintyre A; Richards C
    BMJ; 1996 Apr; 312(7038):1096-7; author reply 1098. PubMed ID: 8616426
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome.
    Stouten B
    QJM; 2004 Jun; 97(6):379-80. PubMed ID: 15152114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.